%0 Journal Article %1 martinezalmoynarifa2025relationship %A Martínez-Almoyna Rifá, Emilio %A López González, Ángel Arturo %A Tárraga López, Pedro Juan %A Paublini, Hernán %A Vallejos, Daniela %A Ramírez Manent, José Ignacio %C Spain %D 2025 %J Nutricion hospitalaria %K grapp-caib %P 10.20960/nh.05441-- %R 10.20960/nh.05441 %T Relationship between diabesity and elevated values of metabolic-associated steatotic liver disease risk scales in Spanish workers using body mass index and the body adiposity estimator criteria of Clínica de Navarra %U https://pubmed.ncbi.nlm.nih.gov/40195779 %X INTRODUCTION: diabesity (coexistence of diabetes and obesity) and metabolic associated steatotic liver disease (MASLD) are two very frequent pathologies whose prevalence is increasing every day. OBJECTIVE: to find out how these two pathological entities are associated in a group of Spanish workers. METHODOLOGY: a descriptive, cross-sectional study was carried out in 219477 workers to assess the association between diabesity (applying a double criterion, the body mass index BMI and the Clínica Universitaria de Navarra body adiposity estimator CUN BAE) and different risk scales for MASLD and liver fibrosis. RESULTS: all MASH and liver fibrosis risk scales show higher values in people with diabesity applying the two criteria compared to people without diabesity. CONCLUSION: diabesity and MASLD and liver fibrosis risk scales show a significant association in our study.

@article{martinezalmoynarifa2025relationship, abstract = {INTRODUCTION: diabesity (coexistence of diabetes and obesity) and metabolic associated steatotic liver disease (MASLD) are two very frequent pathologies whose prevalence is increasing every day. OBJECTIVE: to find out how these two pathological entities are associated in a group of Spanish workers. METHODOLOGY: a descriptive, cross-sectional study was carried out in 219477 workers to assess the association between diabesity (applying a double criterion, the body mass index BMI and the Clínica Universitaria de Navarra body adiposity estimator CUN BAE) and different risk scales for MASLD and liver fibrosis. RESULTS: all MASH and liver fibrosis risk scales show higher values in people with diabesity applying the two criteria compared to people without diabesity. CONCLUSION: diabesity and MASLD and liver fibrosis risk scales show a significant association in our study.}, added-at = {2025-04-14T10:49:29.000+0200}, address = {Spain}, author = {Martínez-Almoyna Rifá, Emilio and López González, Ángel Arturo and Tárraga López, Pedro Juan and Paublini, Hernán and Vallejos, Daniela and Ramírez Manent, José Ignacio}, biburl = {https://www.bibsonomy.org/bibtex/2af68ff2a0fa2b983f4061e73ade555ce/nachoricci}, comment = {40195779[pmid]}, description = {[Relationship between diabesity and elevated values of metabolic-associated steatotic liver disease risk scales in Spanish workers using body mass index and the body adiposity estimator criteria of Clínica de Navarra] - PubMed}, doi = {10.20960/nh.05441}, interhash = {d4647c7800ab7dafdcf1941881f15356}, intrahash = {af68ff2a0fa2b983f4061e73ade555ce}, issn = {16995198}, journal = {Nutricion hospitalaria}, keywords = {grapp-caib}, month = mar, pages = {10.20960/nh.05441--}, timestamp = {2025-04-14T10:49:29.000+0200}, title = {Relationship between diabesity and elevated values of metabolic-associated steatotic liver disease risk scales in Spanish workers using body mass index and the body adiposity estimator criteria of Clínica de Navarra}, url = {https://pubmed.ncbi.nlm.nih.gov/40195779}, year = 2025 }